Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis

NCT05399641 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Vulvovaginal Candidiasis

Interventions

DRUG: Ibrexafungerp

Sponsor

Scynexis, Inc.